Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Investigational new drugs

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00173503PMID 3583642
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

  1985cited by this paper
• Potentiation and protection of doxorubicin cytotoxicity by cellular glutathione modulation.

  1985cited by this paper
• Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine.

  1985cited by this paper
• Evaluation of an automated image analysis system for counting human tumor colonies.

  1984cited by this paper
• Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.

  1984cited by this paper
• Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard.

  1984cited by this paper
• Glutathione-conferred resistance to antineoplastics: approaches toward its reduction.

  1984cited by this paper
• Glutathione depletion in tissues after administration of buthionine sulphoximine.

  1984cited by this paper
• Inhibition of Glutathione Synthesis

  1983cited by this paper
• The role of thiols in cellular response to radiation and drugs.

  1983cited by this paper
• Selective modification of glutathione metabolism.

  1983cited by this paper
• Inhibition of glutathione synthesis augments lysis of murine tumor cells by sulfhydryl-reactive antineoplastics.

  1983cited by this paper
• Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis.

  1982cited by this paper
• Glutathione export by human lymphoid cells: depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation.

  1981influential reference
• Growth characteristics of MOPC-315 plasmacytoma and response to anticancer agents.

  1981cited by this paper
• Depletion of glutathione selectively inhibits synthesis of leukotriene C by macrophages.

  1981cited by this paper
• Glutathione turnover in human erythrocytes. Inhibition by buthionine sulfoximine and incorporation of glycine by exchange.

  1981cited by this paper
• Cardiac glutathione: diurnal rhythm and variation in drug-induced cardiomyopathy.

  1979cited by this paper
• Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

  1979cited by this paper
• Characterization of WiDr: A human colon carcinoma cell line

  1979cited by this paper
• The nature of cells generating human myeloma colonies in vitro

  1979cited by this paper
• Primary bioassay of human tumor stem cells.

  1977cited by this paper
• A human cell line from a pleural effusion derived from a breast carcinoma.

  1973cited by this paper
• Ascorbic Acid: A Culture Requirement for Colony Formation by Mouse Plasmacytoma Cells

  1971cited by this paper
• Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent.

  1968cited by this paper
• Production of Free Light Chains of Immunoglobulin by a Hematopoietic Cell Line Derived from a Patient with Multiple Myeloma.∗

  1967cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Preclinical screening and evaluation of agents for the chemotherapy of cancer: a review.

  1961cited by this paper
• Studies on eight transplantable plasma-cell neoplasms of mice.

  1960cited by this paper

• Host glutathione is required for Rickettsia parkeri cell division and intracellular survival

  2025cites this paper
• Rational design of alternative treatment options for radioresistant rectal cancer using patient-derived organoids

  2025cites this paper
• Buthionine sulfoximine and chemoresistance in cancer treatments: a systematic review with meta-analysis of preclinical studies

  2023influential citation
• Inhibition of the glutamate-cysteine ligase catalytic subunit with buthionine sulfoximine enhances the cytotoxic effect of doxorubicin and cyclophosphamide in Burkitt lymphoma cells

  2023cites this paper
• Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE

  2023cites this paper
• Design and synthesis of isothiocyanate‐containing hybrid androgen receptor (AR) antagonist to downregulate AR and induce ferroptosis in GSH–Deficient prostate cancer cells

  2021cites this paper
• Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine

  2016cites this paper
• The chemistry of aminoferrocene, Fe{(η5-C5H4NH2)(η5-Cp)}: Synthesis, reactivity and applications

  2016cites this paper
• Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8(+) T cell function by limiting GSH and Cys availability.

  2015influential citation
• 2-Phenylethynesulfonamide (PES) uncovers a necrotic process regulated by oxidative stress and p53.

  2014cites this paper
• The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma

  2014cites this paper
• Aminoferrocene-based prodrugs and their effects on human normal and cancer cells as well as bacterial cells.

  2013cites this paper
• Aminoferrocene-based prodrugs activated by reactive oxygen species.

  2012cites this paper
• Anti-colorectal cancer activity of an organometallic osmium arene azopyridine complex

  2011cites this paper
• Optimization of the Antitumor Activity of Sequence-specific Pyrrolobenzodiazepine Derivatives Based on their Affinity for ABC Transporters

  2010influential citation
• Its Effect on Melphalan-induced Toxicity in Mice Pharmacokinetics of Buthionine Sulfoximine ( NSC 326231 ) and Updated Version

  2006cites this paper
• Oxidative stress and apoptosis: a new treatment paradigm in cancer.

  2006cites this paper
• Glutathione, Ascorbate, and Cellular Protection1

  2006cites this paper
• Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.

  2005cites this paper
• Catecholamines in a macrophage cell line.

  2003cites this paper
• Arsenic trioxide cytotoxicity in steroid and chemotherapy-resistant myeloma cell lines: enhancement of apoptosis by manipulation of cellular redox state.

  2002cites this paper
• l-Buthionine Sulfoximine Potentiates the Antitumor Effect of 4-Hydroperoxycyclophosphamide When Administered Locally in a Rat Glioma Model

  2001cites this paper
• Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon.

  2000cites this paper
• Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis.

  1999cites this paper
• Selective toxicity of buthionine sulfoximine (BSO) to melanoma cells in vitro and in vivo.

  1994cites this paper
• Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.

  1994cites this paper
• Effect of sulfhydryl compounds and glutathione depletion on rat heart myocyte toxicity induced by 4-hydroperoxycyclophosphamide and acrolein in vitro.

  1994cites this paper
• Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan.

  1992cites this paper
• Enhancement of melphalan-induced gastrointestinal toxicity in mice treated with regional hyperthermia and BSO-mediated glutathione depletion.

  1992cites this paper
• Conjugation of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion.

  1990cites this paper
• Metabolism and action of amino acid analog anti-cancer agents.

  1990cites this paper
• Effects of L-phenylalanine mustard and L-buthionine sulfoximine on murine and human hematopoietic progenitor cells in vitro.

  1990cites this paper
• Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.

  1989cites this paper
• Attempted modulation of disulfide antitumor activity in Balb/c mice through glutathione depletion.

  1989cites this paper
• Lack of enhanced antitumor efficacy for L-buthionine sulfoximine in combination with carmustine, cyclophosphamide, doxorubicin or melphalan in mice.

  1988cites this paper